1. Home
  2. PEN
  3. PEN News

Latest Penumbra Inc. (PEN) News on May 10, 2025

PEN

Argus Research

3 days ago

PEN: Lowering target price to $307.00

Spotify Breaks Out After Apple Ruling, Leads 5 Stocks Near Buy Points
PEN

Investor's Business Daily

7 days ago

Spotify Breaks Out After Apple Ruling, Leads 5 Stocks Near Buy Points

3 Profitable Stocks in the Doghouse
PEN

StockStory

9 days ago

3 Profitable Stocks in the Doghouse

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
PEN

PR Newswire

10 days ago

Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

3 Reasons Growth Investors Will Love Penumbra (PEN)
PEN

Zacks

12 days ago

3 Reasons Growth Investors Will Love Penumbra (PEN)

Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
PEN

Zacks

12 days ago

Why Penumbra (PEN) is a Top Growth Stock for the Long-Term

Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
PEN

Simply Wall St.

14 days ago

Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Penumbra First Quarter 2025 Earnings: Beats Expectations
PEN

Simply Wall St.

15 days ago

Penumbra First Quarter 2025 Earnings: Beats Expectations

Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand
PEN

Zacks

16 days ago

Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand

PEN

Thomson Reuters StreetEvents

16 days ago

Q1 2025 Penumbra Inc Earnings Call

Penumbra Inc (PEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst International ...
PEN

GuruFocus.com

16 days ago

Penumbra Inc (PEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst International ...

Penumbra (PEN) Reports Q1 Earnings: What Key Metrics Have to Say
PEN

Zacks

16 days ago

Penumbra (PEN) Reports Q1 Earnings: What Key Metrics Have to Say

Penumbra’s (NYSE:PEN) Q1 Sales Beat Estimates, Stock Soars
PEN

StockStory

16 days ago

Penumbra’s (NYSE:PEN) Q1 Sales Beat Estimates, Stock Soars

Penumbra (PEN) Q1 Earnings and Revenues Top Estimates
PEN

Zacks

16 days ago

Penumbra (PEN) Q1 Earnings and Revenues Top Estimates

PEN

MT Newswires

16 days ago

Penumbra Q1 Non-GAAP Earnings, Revenue Rise; Shares Gain After Hours

PEN

Associated Press Finance

16 days ago

Penumbra: Q1 Earnings Snapshot

Penumbra, Inc. Reports First Quarter 2025 Financial Results
PEN

PR Newswire

16 days ago

Penumbra, Inc. Reports First Quarter 2025 Financial Results

Dow Jones Leader Verizon Eyes Buy Point; Netflix Breaks Out On Earnings
PEN

Investor's Business Daily

17 days ago

Dow Jones Leader Verizon Eyes Buy Point; Netflix Breaks Out On Earnings

Stroke Management Drug Firm Climbs To Key Level Ahead Of Earnings; But Beware This Pharma Tariff
PEN

Investor's Business Daily

18 days ago

Stroke Management Drug Firm Climbs To Key Level Ahead Of Earnings; But Beware This Pharma Tariff

What To Expect From Penumbra’s (PEN) Q1 Earnings
PEN

StockStory

18 days ago

What To Expect From Penumbra’s (PEN) Q1 Earnings

Why Penumbra (PEN) is Poised to Beat Earnings Estimates Again
PEN

Zacks

19 days ago

Why Penumbra (PEN) is Poised to Beat Earnings Estimates Again

Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)
PEN

StockStory

23 days ago

Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)

Penumbra (PEN) Earnings Expected to Grow: Should You Buy?
PEN

Zacks

24 days ago

Penumbra (PEN) Earnings Expected to Grow: Should You Buy?

PEN

Argus Research

24 days ago

PEN: Raising target price to $286.00

Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
PEN

StockStory

25 days ago

Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

3 Reasons PEN is Risky and 1 Stock to Buy Instead
PEN

StockStory

a month ago

3 Reasons PEN is Risky and 1 Stock to Buy Instead

PEN

Argus Research

a month ago

PEN: Lowering target price to $269.00

Reasons to Retain Penumbra Stock in Your Portfolio for Now
PEN

Zacks

a month ago

Reasons to Retain Penumbra Stock in Your Portfolio for Now

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025
PEN

PR Newswire

a month ago

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
PEN

PR Newswire

a month ago

Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits

PEN

Argus Research

a month ago

PEN: Lowering target price to $285.00

Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue?
PEN

Zacks

a month ago

Veracyte (VCYT) Up 0.7% Since Last Earnings Report: Can It Continue?

Alcon Stock Sees RS Rating Climb To 74
PEN

Investor's Business Daily

a month ago

Alcon Stock Sees RS Rating Climb To 74

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch
PEN

StockStory

a month ago

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues
PEN

Zacks

2 months ago

New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues

Do Its Financials Have Any Role To Play In Driving Penumbra, Inc.'s (NYSE:PEN) Stock Up Recently?
PEN

Simply Wall St.

2 months ago

Do Its Financials Have Any Role To Play In Driving Penumbra, Inc.'s (NYSE:PEN) Stock Up Recently?

Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound?
PEN

Zacks

2 months ago

Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound?

Chipotle upgraded, Charter initiated: Wall Street’s top analyst calls
PEN

TipRanks

2 months ago

Chipotle upgraded, Charter initiated: Wall Street’s top analyst calls

PEN

Argus Research

2 months ago

PEN: Raising target price to $298.00

Alcon Stock Gets Relative Strength Rating Lift
PEN

Investor's Business Daily

2 months ago

Alcon Stock Gets Relative Strength Rating Lift

Growing Thrombectomy Business Supports PEN Stock, Macro Issues Ail
PEN

Zacks

2 months ago

Growing Thrombectomy Business Supports PEN Stock, Macro Issues Ail

3 Mid-Cap Stocks in Hot Water
PEN

StockStory

2 months ago

3 Mid-Cap Stocks in Hot Water

PEN

Argus Research

2 months ago

PEN: Raising target price to $296.00

Penumbra, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
PEN

Simply Wall St.

3 months ago

Penumbra, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
PEN

PR Newswire

3 months ago

Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors

Penumbra (PEN) Upgraded to Buy: Here's Why
PEN

Zacks

3 months ago

Penumbra (PEN) Upgraded to Buy: Here's Why

Penumbra Full Year 2024 Earnings: EPS Misses Expectations
PEN

Simply Wall St.

3 months ago

Penumbra Full Year 2024 Earnings: EPS Misses Expectations

Profit Machine Penumbra Surges On Solid Fourth-Quarter Beat, But Guidance Lags
PEN

Investor's Business Daily

3 months ago

Profit Machine Penumbra Surges On Solid Fourth-Quarter Beat, But Guidance Lags

Why Penumbra (PEN) Stock Is Trading Up Today
PEN

StockStory

3 months ago

Why Penumbra (PEN) Stock Is Trading Up Today

PEN

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Penumbra Inc Earnings Call

Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises
PEN

Zacks

3 months ago

Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises

Penumbra Inc (PEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid International ...
PEN

GuruFocus.com

3 months ago

Penumbra Inc (PEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid International ...

PEN

Argus Research

3 months ago

PEN: Raising target price to $285.00

Here's What Key Metrics Tell Us About Penumbra (PEN) Q4 Earnings
PEN

Zacks

3 months ago

Here's What Key Metrics Tell Us About Penumbra (PEN) Q4 Earnings

Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates
PEN

Zacks

3 months ago

Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates

PEN

Associated Press Finance

3 months ago

Penumbra: Q4 Earnings Snapshot

Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates
PEN

StockStory

3 months ago

Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates

Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
PEN

StockStory

3 months ago

Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
PEN

StockStory

3 months ago

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
PEN

StockStory

3 months ago

Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
PEN

StockStory

3 months ago

Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
PEN

StockStory

3 months ago

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest

Should You Add Penumbra Stock to Your Portfolio Right Now?
PEN

Zacks

3 months ago

Should You Add Penumbra Stock to Your Portfolio Right Now?

PEN

Argus Research

3 months ago

PEN: Lowering target price to $275.00

PEN

Argus Research

3 months ago

PEN: Rating increased to a HOLD

PEN

Argus Research

4 months ago

PEN: Raising target price to $215.00

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025
PEN

PR Newswire

4 months ago

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025

Buy 4 Low-Beta Stocks AVO, TXO, PEN & STRA to Beat Market Volatility
PEN

Zacks

4 months ago

Buy 4 Low-Beta Stocks AVO, TXO, PEN & STRA to Beat Market Volatility

3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
PEN

Zacks

4 months ago

3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)

Zacks.com featured highlights YPF Sociedad, Telefonica, Penumbra, Deckers Outdoor and Abercrombie & Fitch
PEN

Zacks

4 months ago

Zacks.com featured highlights YPF Sociedad, Telefonica, Penumbra, Deckers Outdoor and Abercrombie & Fitch

PEN

Argus Research

4 months ago

PEN: Raising target price to $207.00

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?
PEN

Zacks

4 months ago

AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?

Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?
PEN

Zacks

4 months ago

Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?

Reasons to Add Penumbra Stock to Your Portfolio Now
PEN

Zacks

4 months ago

Reasons to Add Penumbra Stock to Your Portfolio Now

Capital Allocation Trends At Penumbra (NYSE:PEN) Aren't Ideal
PEN

Simply Wall St.

4 months ago

Capital Allocation Trends At Penumbra (NYSE:PEN) Aren't Ideal

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PEN

PR Newswire

4 months ago

Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
PEN

Zacks

4 months ago

Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"

PEN

Argus Research

5 months ago

PEN: Lowering target price to $201.00

Here's Why Penumbra (PEN) is a Strong Growth Stock
PEN

Zacks

5 months ago

Here's Why Penumbra (PEN) is a Strong Growth Stock

4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
PEN

Zacks

5 months ago

4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025

Penumbra price target raised to $285 from $240 at Truist
PEN

TipRanks

5 months ago

Penumbra price target raised to $285 from $240 at Truist

PEN

Argus Research

5 months ago

PEN: Raising target price to $204.00

PEN

Argus Research

5 months ago

PEN: Lowering target price to $202.00

Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why
PEN

Zacks

5 months ago

Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why

Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
PEN

Zacks

5 months ago

Why Penumbra (PEN) is a Top Growth Stock for the Long-Term

Investing in Penumbra (NYSE:PEN) five years ago would have delivered you a 55% gain
PEN

Simply Wall St.

5 months ago

Investing in Penumbra (NYSE:PEN) five years ago would have delivered you a 55% gain

PEN

Argus Research

5 months ago

PEN: Lowering target price to $203.00

Is Penumbra Stock a Smart Buy for Your Portfolio Right Now?
PEN

Zacks

5 months ago

Is Penumbra Stock a Smart Buy for Your Portfolio Right Now?

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?
PEN

Zacks

5 months ago

Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?

PEN

Argus Research

5 months ago

PEN: Raising target price to $205.00

Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization with New FDA-Approved Technologies
PEN

Insider Monkey

5 months ago

Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization with New FDA-Approved Technologies

Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
PEN

Zacks

6 months ago

Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?

3 Reasons Growth Investors Will Love Penumbra (PEN)
PEN

Zacks

6 months ago

3 Reasons Growth Investors Will Love Penumbra (PEN)

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
PEN

PR Newswire

6 months ago

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

Inside a $400 billion bet on the brain-computer interface revolution
PEN

Yahoo Finance

6 months ago

Inside a $400 billion bet on the brain-computer interface revolution

Penumbra, Inc. (PEN): A Bull Case Theory
PEN

Insider Monkey

6 months ago

Penumbra, Inc. (PEN): A Bull Case Theory

PEN

Argus Research

6 months ago

PEN: Raising target price to $195.00

There May Be Some Bright Spots In Penumbra's (NYSE:PEN) Earnings
PEN

Simply Wall St.

6 months ago

There May Be Some Bright Spots In Penumbra's (NYSE:PEN) Earnings

Penumbra reveals positive data for algorithm-assisted thrombectomy tech
PEN

Clinical Trials Arena

6 months ago

Penumbra reveals positive data for algorithm-assisted thrombectomy tech

PEN

Argus Research

6 months ago

PEN: Raising target price to $193.00

Share on Social Networks: